ABT:NYE-Abbott Laboratories

EQUITY | Medical Devices | New York Stock Exchange

Last Closing

USD 83.81

Change

-0.11 (-0.13)%

Market Cap

USD 56.45B

Volume

5.18M

Analyst Target

USD 83.06
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Abbott Laboratories discovers, develops, manufactures and sells health care products. Its products include branded generic pharmaceuticals manufactured internationally, marketed and sold outside the United States.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-07-15 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
SYK Stryker Corporation

+2.25 (+0.69%)

USD 133.55B
MDT Medtronic PLC

+1.09 (+1.37%)

USD 112.28B
BSX Boston Scientific Corp

+0.69 (+1.02%)

USD 98.97B
EW Edwards Lifesciences Corp

+1.02 (+1.19%)

USD 55.80B
ZBH Zimmer Biomet Holdings Inc

+1.35 (+1.13%)

USD 26.16B
STE STERIS plc

+1.39 (+0.70%)

USD 21.09B
PHG Koninklijke Philips NV ADR

+0.63 (+3.15%)

USD 18.20B
SNN Smith & Nephew SNATS Inc

+0.52 (+2.18%)

USD 10.70B
BIO Bio-Rad Laboratories Inc

+0.40 (+0.14%)

USD 7.99B
BIO-B Bio-Rad Laboratories Inc

N/A

USD 7.98B

ETFs Containing ABT

UMDV:SW iShares US Medical Device.. 18.01 % 0.00 %

-0.01 (0.00%)

USD 0.18B
EDOC:AU BetaShares Digital Health.. 9.14 % 0.00 %

N/A

N/A
PJP Invesco Dynamic Pharmaceu.. 5.50 % 0.56 %

-0.07 (0.00%)

USD 0.26B
LIFE-B:CA Evolve Global Healthcare .. 5.18 % 0.00 %

N/A

CAD 0.01B
ZWHC:CA BMO Covered Call Health C.. 5.00 % 0.00 %

+0.21 (+0.00%)

CAD 0.01B
XDG3:XETRA Xtrackers MSCI Global SDG.. 4.77 % 0.00 %

+0.32 (+0.00%)

USD 0.15B
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.76 % 0.00 %

+0.22 (+0.00%)

USD 3.51M
HART IQ Healthy Hearts ETF 4.66 % 0.00 %

+0.23 (+0.00%)

USD 8.64M
XGES:LSE Xtrackers MSCI Genomic He.. 4.34 % 0.00 %

+0.30 (+0.00%)

USD 3.51M
XGSD:SW Xtrackers Stoxx Global Se.. 4.14 % 0.00 %

+0.42 (+0.00%)

USD 0.59B
XGSD:XETRA Xtrackers Stoxx Global Se.. 4.14 % 0.00 %

+0.18 (+0.00%)

N/A
IUHC:SW iShares S&P 500 Health Ca.. 3.83 % 0.00 %

N/A

USD 2.07B
SXLV:SW SPDR S&P U.S. Health Care.. 3.83 % 0.00 %

+0.17 (+0.00%)

N/A
XUHC:SW Xtrackers MSCI USA Health.. 3.72 % 0.00 %

+0.45 (+0.00%)

USD 0.81B
IUAE:CA Invesco S&P US Dividend A.. 3.68 % 0.00 %

+0.09 (+0.00%)

CAD 1.10M
GXLV:LSE SPDR® S&P® U.S. Health .. 3.61 % 0.00 %

+0.40 (+0.00%)

USD 0.39B
XLV Health Care Select Sector.. 3.59 % 0.13 %

+0.53 (+0.00%)

USD 37.76B
WELG:XETRA Amundi S&P Global Health .. 3.53 % 0.00 %

+0.10 (+0.00%)

USD 0.24B
WELS:XETRA Amundi S&P Global Health .. 3.53 % 0.00 %

+0.10 (+0.00%)

USD 0.24B
IYH iShares U.S. Healthcare E.. 3.43 % 0.43 %

+0.27 (+0.00%)

USD 3.23B
QLTY GMO U.S. Quality ETF 3.42 % 0.00 %

+0.19 (+0.00%)

USD 0.44B
VHT Vanguard Health Care Inde.. 3.17 % 0.10 %

+1.20 (+0.00%)

USD 16.98B
FHLC Fidelity® MSCI Health Ca.. 3.15 % 0.08 %

+0.23 (+0.00%)

USD 2.94B
AIVL WisdomTree Trust - Wisdom.. 2.82 % 0.00 %

+0.70 (+0.00%)

USD 0.36B
HEAL:CA 2.82 % 0.00 %

N/A

N/A
WHEA:SW SPDR MSCI World Health Ca.. 2.69 % 0.00 %

N/A

N/A
HEAW:LSE SPDR® MSCI World Health .. 2.53 % 0.00 %

+0.64 (+0.00%)

USD 0.57B
CGDV Capital Group Dividend Va.. 2.45 % 0.00 %

+0.26 (+0.00%)

USD 6.90B
CGUS Capital Group Core Equity.. 2.27 % 0.00 %

+0.23 (+0.00%)

USD 2.42B
SNPV 1.82 % 0.00 %

N/A

N/A
OALC Unified Series Trust 1.80 % 0.00 %

+0.22 (+0.00%)

USD 0.10B
HYLG Global X Funds - Global X.. 1.68 % 0.00 %

-0.04 (0.00%)

USD 2.85M
CURE Direxion Daily Healthcare.. 0.00 % 1.06 %

+1.10 (+0.00%)

USD 0.21B
IHI iShares U.S. Medical Devi.. 0.00 % 0.43 %

+0.34 (+0.00%)

USD 5.55B
IXJ iShares Global Healthcare.. 0.00 % 0.46 %

+0.66 (+0.00%)

USD 4.11B
JHMH 0.00 % 0.46 %

N/A

N/A
QDYN 0.00 % 0.37 %

N/A

N/A
ACT Enact Holdings Inc 0.00 % 0.75 %

+0.17 (+0.00%)

USD 4.70B
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

N/A

CAD 0.08B
RWDC 0.00 % 0.00 %

N/A

N/A
GDNA 0.00 % 0.00 %

N/A

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

-0.08 (0.00%)

USD 1.09M
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

-0.08 (0.00%)

USD 1.09M
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

+0.69 (+0.00%)

USD 0.09B
XHC:CA iShares Global Healthcare.. 0.00 % 0.65 %

+0.54 (+0.00%)

CAD 0.58B
LIFE:CA Evolve Global Healthcare .. 0.00 % 0.69 %

+0.19 (+0.00%)

CAD 0.01B
IHCU:LSE iShares S&P 500 Health Ca.. 0.00 % 0.00 %

+11.63 (+0.00%)

USD 1.69B
IUHC:LSE iShares S&P 500 USD Healt.. 0.00 % 0.00 %

+0.07 (+0.00%)

USD 2.07B
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

+0.23 (+0.00%)

USD 0.40B
WHEA:LSE SPDR® MSCI World Health .. 0.00 % 0.00 %

+0.48 (+0.00%)

USD 0.59B
XDWH:LSE Xtrackers MSCI World Heal.. 0.00 % 0.00 %

+0.36 (+0.00%)

USD 2.64B
XGDD:LSE Xtrackers - Stoxx Global .. 0.00 % 0.00 %

+0.12 (+0.00%)

USD 0.50M
XGSD:LSE Xtrackers Stoxx Global Se.. 0.00 % 0.00 %

+24.50 (+0.00%)

USD 0.59B
XSHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

+51.50 (+0.00%)

USD 1.04B
XUHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

+0.28 (+0.00%)

USD 1.04B
DXSB:F Xtrackers - Stoxx Global .. 0.00 % 0.00 %

N/A

USD 0.60B
QDVG:F iShares S&P 500 Health Ca.. 0.00 % 0.00 %

+0.08 (+0.00%)

USD 2.09B
XDWH:F Xtrackers (IE) Public Lim.. 0.00 % 0.00 %

+0.52 (+0.00%)

USD 2.60B
XUHC:F Xtrackers (IE) Public Lim.. 0.00 % 0.00 %

+0.41 (+0.00%)

USD 0.85B
ZPDH:F SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

+0.34 (+0.00%)

USD 0.40B
DXSB:XETRA Xtrackers - Stoxx Global .. 0.00 % 0.00 %

+0.18 (+0.00%)

USD 0.68B
QDVG:XETRA iShares S&P 500 Health Ca.. 0.00 % 0.00 %

+0.08 (+0.00%)

USD 2.05B
XDWH:XETRA Xtrackers MSCI World Heal.. 0.00 % 0.00 %

+0.47 (+0.00%)

USD 2.60B
XUHC:XETRA Xtrackers MSCI USA Health.. 0.00 % 0.00 %

+0.36 (+0.00%)

USD 0.85B
ZPDH:XETRA SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

+0.28 (+0.00%)

USD 0.40B
HIG-U:CA 0.00 % 0.00 %

N/A

N/A
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
IXJ:AU iShares Global Healthcare.. 0.00 % 0.00 %

+1.04 (+0.00%)

USD 1.35B
FUD-A:CA 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.87% 50% F 59% D-
Dividend Return 1.33% 100% F 42% F
Total Return 17.20% 50% F 58% F
Trailing 12 Months  
Capital Gain 32.91% 93% A 95% A
Dividend Return 1.97% 67% D+ 38% F
Total Return 34.87% 93% A 94% A
Trailing 5 Years  
Capital Gain 103.57% 64% D 91% A-
Dividend Return 13.02% 71% C- 50% F
Total Return 116.59% 64% D 91% A-
Average Annual (5 Year Horizon)  
Capital Gain 14.22% 50% F 72% C
Dividend Return 16.50% 50% F 72% C
Total Return 2.29% 100% F 57% F
Risk Return Profile  
Volatility (Standard Deviation) 19.70% 57% F 63% D
Risk Adjusted Return 83.77% 57% F 89% A-
Market Capitalization 56.45B 100% F 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Devices) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 43.70 25% 10%
Price/Book Ratio 4.78 43% 21%
Price / Cash Flow Ratio 0.00 73% 60%
Price/Free Cash Flow Ratio 0.00 73% 52%
Management Effectiveness  
Return on Equity 8.28% 67% 53%
Return on Invested Capital N/A N/A N/A
Return on Assets 3.71% 57% 62%
Debt to Equity Ratio 63.42% 41% 55%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector